期刊文献+

Enhanced Anticancer Cells Effects of Optimized Suspension Stable As2O3-Loaded Poly(lactic-co-glycolic acid) Nanocapsules

Enhanced Anticancer Cells Effects of Optimized Suspension Stable As2O3-Loaded Poly(lactic-co-glycolic acid) Nanocapsules
原文传递
导出
摘要 This study is to prepare a nanosuspension based on poly(lactic-co-glycolic acid) (PLGA) for delivery, controlled release and enhanced anti-solid tumor effects of As2O3. As2O3-1oaded PLGA nanocapsules (As2O3-PLGANCs) were prepared by double emulsion-solvent evaporation method and were optimized by univariate analysis in combination with orthogonal experimental according to several factors. The optimized As2O3-PLGA NCs presented suitable physical stability, favorable size of (200.2± 10.6) nm (PDI=0.117 ±0.008), spherical shape, and high encapsulation efficiency (92.48%± 2.14%). The in vitro suspension stability of the NCs was excellent. The release of As2O3 from the NCs showed pH responsive release characteristics. The NCs can be efficiently taken up by SMMC-7721 cell and showed excellent antitumor efficacy against SMMC-7721 cell line. Then, As2O3-PLGA NCs could be considered as a promising formulation for the pH dependent release of As2O3 in cancer cells and enhance the anti-solid tumor effects of As2O3. This study is to prepare a nanosuspension based on poly(lactic-co-glycolic acid) (PLGA) for delivery, controlled release and enhanced anti-solid tumor effects of As2O3. As2O3-1oaded PLGA nanocapsules (As2O3-PLGANCs) were prepared by double emulsion-solvent evaporation method and were optimized by univariate analysis in combination with orthogonal experimental according to several factors. The optimized As2O3-PLGA NCs presented suitable physical stability, favorable size of (200.2± 10.6) nm (PDI=0.117 ±0.008), spherical shape, and high encapsulation efficiency (92.48%± 2.14%). The in vitro suspension stability of the NCs was excellent. The release of As2O3 from the NCs showed pH responsive release characteristics. The NCs can be efficiently taken up by SMMC-7721 cell and showed excellent antitumor efficacy against SMMC-7721 cell line. Then, As2O3-PLGA NCs could be considered as a promising formulation for the pH dependent release of As2O3 in cancer cells and enhance the anti-solid tumor effects of As2O3.
出处 《Chinese Journal of Chemistry》 SCIE CAS CSCD 2015年第7期777-784,共8页 中国化学(英文版)
基金 This research was supported by the National Natural Science Foundation of China (No. 21201149), the Natural Science Foundation of Jiangsu Province (No. BK2012259), the Project of the Testing Center of Yangzhou University (China), the Postdoctoral Science Foundation and the Priority Academic Program Development of Jiangsu Higher Education Institutions.
关键词 As2O3-PLGA nanocapsules orthogonal experiment suspension stability drug delivery As2O3-PLGA nanocapsules, orthogonal experiment, suspension stability, drug delivery
  • 相关文献

参考文献31

  • 1Zhu, J.; Chen, Z.; Lallemand-Breitenbach, V. Nat. Rev. Cancer 2002 2, 705.
  • 2Wang, Z. Y.; Chen, Z. 2008, 111, 2505.
  • 3Yu, H.; Zhu, G. Y.; Xu, R. Z.; Niu, H. Z.; Lu, Q.; Li, G. Z.; Wang, Z Y.; Zhang, D. S.; Gu, N.; Teng, G. J. Int. J. Hyperthermia 2011, 18, 267.
  • 4Chen, H.; Ahn, R.; Van den Bossche, J.; Thompson, D. H.; O'Halloran, T. V. Mol. Cancer Ther. 2009, 8, 1955.
  • 5Ahn, R. W.; Chen, F.; Chert, H. M.; Stem, S. T.; Clogston, J. D.; Pa- tri, A. K.; Raja, M. R.; Swindell, E. P.; Parimi, V.; Cryns, V. L. Cancer Clin. Cancer Res. 2010, 16, 3607.
  • 6Ni, J.; Chen, G.; Shen, Z.; Li, X.; Liu, H.; Huang, Y.; Fang, Z.; Chen, S.; Wang, Z.; Chen, Z. Chin. Med. J. 1998, 111, 1107.
  • 7Efthimiadou, E. K.; Tziveleka, L. A.; Bilalis, P.; Kordas, G. Int. J. Pharm. 2012, 428, 134.
  • 8Yu, H. Y.; Tang, Z. H.; Song, W. T.; Deng, M. X.; Chen, X. Chem. J. Chin. Univ. 2012, 33, 2809 (in Chinese).
  • 9Paun, I. A.; Moldovanb, A.; Luculescu, C. R.; Dinescu, M. Appl. Surf. Sci. 2011, 257, 10780.
  • 10Acharya, S.; Sahoo, S. K. Adv. Drug Deliver. Rev. 2011, 63, 170.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部